EAM INVESTORS, LLC Revance Therapeutics, Inc. Transaction History

EAM INVESTORS, LLC portfolio value:

$2.54M
portfolio value

Revance Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 94.41K shares 2.54M $27 94.41K
Q4 2020 share Decrease -100.00% -42.53K shares -1.06M $28.34 0
Q3 2020 share Increase +34.82% 10.98K shares 299K $25.14 42.53K
Q2 2020 share Decrease -63.01% -53.75K shares -492K $24.42 31.55K
Q1 2020 share Decrease -19.09% -20.12K shares -449K $14.8 85.30K
Q4 2019 share Increase 0.00% 105.42K shares 1.71M $16.23 105.42K
Q2 2018 share Decrease -100.00% -113.09K shares -3.48M $27.45 0
Q1 2018 share Increase +5.37% 5.76K shares -354K $30.8 113.09K
Q4 2017 share Increase +48.01% 34.81K shares 1.83M $35.75 107.33K
Q3 2017 share Increase +113.94% 38.62K shares 1.10M $27.55 72.51K
Q2 2017 share Increase 0.00% 33.89K shares 895K $26.4 33.89K
Q1 2016 share Decrease -100.00% -102.8K shares -3.51M $17.46 0